Roku Inc (ROKU : NASDAQ)
Common Stock
$155.33
USD
-1.33 (-0.85%)
Last updated: 2026-10-28
Follow ROKU
ROKU
Roku Inc
WealthAwesomePerformance
1 Day
-0.85%
1 Week
-1.55%
1 Month
+1.74%
YTD
+42.87%
Key Statistics
Market Cap
$23.16B
52W High
$160.22
52W Low
$78.53
P/E Ratio
66.36
50 Day MA
$155.25
200 Day MA
$127.04
Beta
2.05
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/28/2026 | $155.95 | $156.64 | $155.00 | $155.33 | $155.33 | 4,086,897 |
| 10/27/2026 | $157.45 | $157.45 | $156.18 | $156.66 | $156.66 | 1,787,135 |
| 10/26/2026 | $158.98 | $159.38 | $156.79 | $157.23 | $157.23 | 1,705,285 |
| 10/23/2026 | $159.34 | $160.22 | $158.52 | $158.58 | $158.58 | 3,271,800 |
| 10/22/2026 | $156.79 | $160.10 | $156.78 | $160.06 | $160.06 | 4,805,404 |
| 10/21/2026 | $157.35 | $158.17 | $155.92 | $157.78 | $157.78 | 6,933,710 |
| 10/20/2026 | $155.81 | $157.57 | $155.12 | $157.57 | $157.57 | 1,373,618 |
| 10/19/2026 | $154.74 | $155.88 | $154.00 | $155.54 | $155.54 | 1,323,666 |
| 10/16/2026 | $155.82 | $156.49 | $153.89 | $154.54 | $154.54 | 1,694,400 |
| 10/15/2026 | $152.84 | $155.13 | $152.84 | $154.67 | $154.67 | 1,784,127 |
Analyst Price Targets
Based on 27 analysts covering ROKU · as of Oct 5, 2026
Wall Street analysts forecast ROKU stock price to rise 4.5% over the next 12 months.
Consensus
Hold3.48 / 5.00
Avg. Target
US$162.33
+4.5% Upside
Current Price
US$155.33
Last close
Analyst Breakdown (27 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ROKU's historical volatility
30-Day Vol
10.7%
Annualized
90-Day Vol
13.8%
Annualized
Trend (90d)
+22.2%
Annualized drift
90d Mean
US$168.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$159.49 | US$153.72 – US$165.48 |
| 60 trading days | US$163.76 | US$155.45 – US$172.53 |
| 90 trading days | US$168.15 | US$157.75 – US$179.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Roku Inc
Roku, Inc., together with its subsidiaries, operates a TV streaming platform in the United States and internationally. The company operates in two segments, Platform and Devices. Its streaming platform allows users to find and access TV shows, movies, news, sports, and others, as well as offers digital advertising services. The company also sells streaming players, Roku-branded TVs, smart home products and services, audio products, and related accessories. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.
Financials
- Revenue (TTM)
- $5.21B
- EBITDA
- $579.00M
- Profit Margin
- 6.82%
- ROE (TTM)
- 13.12%
- EPS (Diluted)
- 2.35
- Book Value
- 19.03
Classification
- Sector
- Communication Services
- Industry
- Entertainment
- Group
- Media & Entertainment
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ROKU.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AXG | Solowin Holdings | $5.68 | +14100.00% |
| ATYR | aTyr Pharma, Inc. | $5.14 | +4041.94% |
| OMEX | Odyssey Marine Exploration Inc | $13.55 | +2418.59% |
| HVII | Hennessy Capital Investment Corp. VII Ordinary Shares | $4.46 | +243.08% |
| ULBI | Ultralife Corporation | $15.61 | +145.44% |
| ATII | Archimedes Tech SPAC Partners II Co. Ordinary Shares | $9.81 | +110.06% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +86.09% |
| KPTI | Karyopharm Therapeutics Inc | $0.83 | +73.35% |
ROKU.US news timeline
5 articles covering ROKU.US, most recent first
Latest